Close Menu
    What's Hot

    The Royal Society of Chemistry Pension Scheme Completes Bulk Purchase Annuity Buy-in With PIC

    August 13, 2026

    US Individual Life Insurance Sales Continue Growth Trend in the Second Quarter

    August 13, 2026

    Editor’s Letter – Volume 2, Issue 8, August 2026

    August 12, 2026
    X (Twitter) LinkedIn
    Longevity & Mortality Investor
    • Home
    • Coverage
      1. Life Insurance Capital Solutions
      2. Life Insurance
      3. Longevity and Mortality Risk Transfer
      4. Mortality
      5. Secondary Life Markets
      6. View All

      Lincoln Financial Reinsures Universal Life Block With Talcott

      August 3, 2026

      US Annuity Sales Set New Quarterly Record in Second Quarter

      August 3, 2026

      Big Year of Growth for Life/Annuity Sidecar-Like Activity in 2025

      July 2, 2026

      Sixth Street To Become Majority Shareholder of Monument Re

      June 30, 2026

      US Individual Life Insurance Sales Continue Growth Trend in the Second Quarter

      August 13, 2026

      Shaping the Future of Health Insurance Through Innovation and Analytics

      June 10, 2026

      Q&A: Dr Christoph Schmitt, Director, Insurance, Fitch Ratings

      May 28, 2026

      Chronic Disease Onset and Cumulative Exposure: Clinical, Prognostic and Underwriting Implications

      May 13, 2026

      US Life Carriers Eyeing VM-22 for a Pension Risk Transfer Pricing Advantage in 2027

      August 12, 2026

      Elementis Group Pension Scheme Completes Bulk Purchase Annuity Buy-In With Aviva

      August 5, 2026

      Hickson UK Group Pension Scheme Completes Bulk Purchase Annuity Transaction With Royal London

      August 3, 2026

      UK Insurance Company Pension Scheme Completes Bulk Purchase Annuity Transaction With M&G

      August 3, 2026

      Record Low Mortality Rates So Far in England and Wales in 2026

      July 9, 2026

      Organ Transplant Improvements Test Life Expectancy Assessment Models

      July 8, 2026

      The Pursuit of Everlasting Life Unlikely to Shift Actuarial Models

      June 10, 2026

      Pricing in the Unknown: Why Mortality Models Aren’t Ready for MCED Tests Just Yet

      April 9, 2026

      The Royal Society of Chemistry Pension Scheme Completes Bulk Purchase Annuity Buy-in With PIC

      August 13, 2026

      New Life Settlement Provider Data Illustrates Continued Evolution of Secondary Life Settlement Market

      August 12, 2026

      The Crucial Role of Regular Medical Record Reviews in Life Settlement Investments

      August 12, 2026

      Corry Capital Advisors Adds John Daniel as Senior Director of Analytics and AI Strategy

      August 6, 2026

      The Royal Society of Chemistry Pension Scheme Completes Bulk Purchase Annuity Buy-in With PIC

      August 13, 2026

      US Individual Life Insurance Sales Continue Growth Trend in the Second Quarter

      August 13, 2026

      Editor’s Letter – Volume 2, Issue 8, August 2026

      August 12, 2026

      New Life Settlement Provider Data Illustrates Continued Evolution of Secondary Life Settlement Market

      August 12, 2026
    • Events
    • Latest Issues

      Editor’s Letter – Volume 2, Issue 8, August 2026

      August 12, 2026

      Editor’s Letter – Volume 2, Issue 7, July 2026

      July 8, 2026

      Editor’s Letter – Volume 2, Issue 6, June 2026

      June 10, 2026

      Editor’s Letter – Volume 2, Issue 5, May 2026

      May 13, 2026

      Editor’s Letter – Volume 2, Issue 4, April 2026

      April 9, 2026
    • Contact Us
    Newsletter
    Longevity & Mortality Investor

    Diversification Isn’t Just an Investing-Related Free Lunch

    Secondary Life Markets April 14, 2023By Greg Winterton
    Silicon Valley
    Share
    Twitter LinkedIn Email

    The recent banking crisis on both sides of the Atlantic has shone a light in asset management circles on the due diligence process undertaken by end investors on their counterparties. A significant percentage of the venture capital industry faced a potential liquidity crisis, and consequently, investors are looking more closely at counterparty risks of all types, not only at the asset manager level, but through to the underlying fund or managed account portfolio level as well.

    Just like many other asset classes in the private markets, counterparty risk in the life risk investing world comes in many forms. In markets such as life settlements and life ILS, the most significant of these is the life insurance company which has issued the insurance policy.

    If a life insurance company were to fail, the first losses would, in theory, be borne by the shareholders and the regulatory surplus capital. But many safeguards exist in the insurance industry at the insurance company level – more so than in the banking industry, where most of the protections are at the consumer level. So, even if there was a technical failure, the assets backing the liabilities should mostly or wholly remain, and policyholders would still be in good standing. Scott Willkomm, Chief Executive Officer at Life Equity LLC, says that, whilst the likelihood of a life insurance company default is low, an obvious first line of defence against this risk presents itself.

    “Most life insurance companies are highly rated, have conservative balance sheets, and benefit from a strong regulatory infrastructure,” he said. “But diversifying counterparty risk is a natural place to start for a simple risk mitigation strategy. Limiting your exposure to a single carrier, regardless of its financial strength, is a prudent approach.”

    The main driver of SVB’s troubles was its investments in longer-dated securities, which presented it with a classic asset/liability duration mismatch. Fortunately for capital markets participants in life risk, there are few similarities between bank and life insurance company balance sheets. Aside from mortality risk, which is hedged differently to assets, economic risks do exist, but rarely in isolation, as they can be within a bank.

    Consequently, the likelihood of an ‘insurance company run’ is improbable. Even if a situation were to occur where every single US universal life insurance policy holder wanted to sell their policy back to the insurance company at the same time – and therefore the insurance company would need to pay out the cash surrender value – this would be a manageable process, as there is no requirement to pay out policy holders the same day and there may be all sorts of management tools to slow the process down or to apply disincentives and penalties.

    Aside from mortality/longevity risks that they themselves run within their pricing, the main day-to-day insurance-related risk, at least in the life settlement market, is the Cost of Insurance risk – the risk that the insurance company increases the COI rates on certain types of policies, the consequence being that these additional costs eat into the eventual investment return. But this is an investment due diligence risk, not an operational one, and certainly with policies funded on a minimum basis, there is little direct asset market risk. Perhaps the closest equivalent of a ‘bank run’ for insurance companies would be an extreme mortality event.

    “The SVB scenario equivalent for a life insurance company could be the onset of a huge pandemic or epidemic – one that would be significantly worse than the recent Covid-19 one,” said Roger Lawrence, Managing Director at consulting firm WL Consulting. “If there was a pandemic which had a much higher mortality rate, insurance companies would be on the hook for a rising rate of pay-outs, which would not only threaten solvency with worse mortality than they planned for, but a need to meet the cash flow of more claims, and every insurer will have a severity threshold at which they couldn’t access the capital to pay the death benefits they are liable for.”

    Pandemic risk is, however, arguably akin to a black swan event and is something outside of the insurance company’s control, whereas the decision to invest in certain illiquid securities, or not, is something that is within a bank’s control. Indeed, the life risk investing industry has long pointed to life insurance companies being robust counterparties, not weak ones. Many have excellent credit ratings, and even tick ESG boxes given the societal benefit of insuring lives and livelihoods.

    “There have been some insolvencies of some small life insurers during the last 7 or 8 years, but the last big company one was about 35 years ago, before the first introduction of risk-based capital regulatory regimes in the 1990s,” said Chris Conway, Chief Development Officer at ISC Services. “Yes, they are different types of businesses serving different purposes. But from a counterparty risk perspective, life-based investors have it pretty good.”

    Bank failures do and will have some impact everywhere, especially if nations refuse to underwrite them. Insurers will suffer within their operational division, losing assets held in cash which may slow claims payments down and at the simplest level, they may not be able to access deposits to pay staff, as was the case with the recent turmoil in venture capital circles. In the life settlement space, another impact of a bank failure is that a bank can also be the securities intermediary and/or custodian. Although custodial roles played by banks should not be a long run counterparty risk, in the short term, there could me a messy hiatus where access to assets is not possible.

    “Ideally, a life settlement fund should not bank with the same firm that it uses as its custodian or securities intermediary for the policies it owns. It’s again a simple case of diversifying risks – if a bank were to go under, then having different firms would at least not stop the operation of the fund even if there are delays in getting access to the policies,” said Lawrence.

    The venture capital industry endured a difficult few days as the SVB debacle unfolded, but ultimately, the US government guaranteed all deposits at those banks, even those above the published $250,000 guarantee. Add to this the bail outs of many banks in many countries during the Global Financial Crisis and it’s easy to succumb to the idea that governments will now guarantee deposits ad infinitum. But you never know, and Lawrence says that for life risk investors, diversification is the name of the game.

    “We might always live in hope for a free lunch, but you are wise to be prepared to buy your own,” he said. “Ensure you do as much due diligence on your operational risk as for your investment risk.”

    2023 - April Volume 2 Issue 4 - April 2023
    Share. Twitter LinkedIn Email

    Related Posts

    UK Pension Regulator Warns Buy-Out Market Demand Could Exceed Capacity

    April 27, 2023By LMI Newsdesk

    Safeway Completes Pension Scheme Derisking With £1.4Bn Buy-In Deal

    April 27, 2023By LMI Newsdesk
    Editor's Letter

    Editor’s Letter – Volume 2, Issue 4, April 2023

    April 14, 2023By Chris Wells

    Life Risk News Volume 2, Issue 4, April 2023 Out Now!

    April 14, 2023By LMI Newsdesk
    Latest Issue

    New Life Settlement Provider Data Illustrates Continued Evolution of Secondary Life Settlement Market

    August 12, 2026

    The Crucial Role of Regular Medical Record Reviews in Life Settlement Investments

    August 12, 2026

    US Life Carriers Eyeing VM-22 for a Pension Risk Transfer Pricing Advantage in 2027

    August 12, 2026

    End-Game Clarity Shaping UK Pension Risk Transfer Market but Large Schemes Still on the Sidelines

    July 22, 2026
    Ad

    Where Longevity and Mortality Meet the Markets
    ISSN 2978-5219

    X (Twitter) LinkedIn
    Coverage
    • Life Insurance Capital Solutions
    • Life Insurance
    • Longevity and Mortality Risk Transfer
    • Mortality Risk
    • Secondary Life Markets
    More Info
    • Home
    • About Us
    • Contact Us
    • Guest Articles
    • Submit Story Idea
    Our Newsletter
    Get the latest industry news, commentary and events from the Longevity & Mortality Investor directly into your inbox. Why not sign up today?

    © 2026 Longevity & Mortality Investor. Website by Kavells.
    • Sitemap
    • Privacy Policy
    • Copyright Notice
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.